Clinical Trial Update: Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study [Phase 4]

View source ↗

Summary

A Sanofi-sponsored Phase 4 trial comparing a basal-bolus insulin strategy using insulin glargine and insulin glulisine versus a premixed insulin strategy in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)
• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED